Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028
Description
Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028
The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.
Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.
Impact of COVID-19 on Global Point of Care Testing Market
The COVID–19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.
The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.
By Diagnostics Segment - Global Point of Care Testing Market & Forecast
Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe.
The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.
Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers.
By Mode - Global Point of Care Testing Market & Forecast
On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.
By Platform - Global Point of Care Testing Market & Forecast
By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period.
By End Users - Global Point of Care Testing Market & Forecast
Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.
By Region - Global Point of Care Testing Market & Forecast
The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.
iGATE RESEARCH report titled “Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028” provides a comprehensive analysis of the Global Point of Care Testing Market.
This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:
1) Global - Point of Care Testing Market & Forecast (2010 - 2028)
2) Impact of COVID-19 on Global Point of Care Testing Market
3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)
4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)
5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)
6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)
7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)
8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)
9) Global Point of Care Testing Market - Recent Developments
10) Global Point of Care Testing Market - 106 Company Profiles
11) Global Point of Care Testing Market - Growth Drivers & Challenges
By Diagnostics Segment - Global Point of Care Testing Market & Forecast
1. Blood Glucose Testing
2. Cardiac Marker Testing
3. Lipid Panel/Cholesterol Testing
4. Coagulation Testing
5. Infectious Disease Testing
6. Urinalysis Testing
7. Drug of Abuse Testing
8. Fecal Occult Blood Testing
9. Pregnancy & Fertility Testing
10. Tumor Marker Testing
11. Critical Care Testing
12. HbA1c Testing
13. Clinical Chemistry Testing
14. Bilirubin Testing
15. Hematology Testing
By Mode - Global Point of Care Testing Market & Forecast
1. Hospitals
2. Clinics
3. Laboratories
4. Assisted Living Healthcare Facilities
5. Home Care
By Region - Global Point of Care Testing Market & Forecast
1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa
Global Point of Care Testing Market - 106 Company Profiles
1. Abbott Laboratories
2. Siemens Healthineers
3. Roche Diagnostics
4. Quest Diagnostics
5. Becton, Dickinson and Company
6. ACON Laboratories
7. Abaxis, Inc
8. Abingdon Health, Ltd
9. Access Bio, Inc.
10. AccuBioTech Co, Ltd.
11. Akers Biosciences, Inc.
12. Alfa Scientific Designs, Inc
13. American Bio Medica Corporation
14. AmniSure International
15. Aquila Diagnostic Systems, Inc
16. ARKRAY Inc
17. Artron Laboratories Inc.
18. Ascensia Diabetes Care Holdings AG
19. Immune IQ (Formerly Ativa)
20. Atlas Link Biotech Co., Ltd
21. Audit Diagnostics
22. Augurix Diagnostics
23. Autobio Diagnostics Co., Ltd
24. Axxin
25. Beckman Coulter, Inc
26. Bhat Bio-Tech India Private Ltd.
27. bioLytical Laboratories
28. BioMedomics, Inc
29. Biomerica, Inc.
30. bioMerieux SA
31. Biophor Diagnostics, Inc
32. Bio-Rad Laboratories Inc.
33. Bioscan Screening Systems, Inc.
34. Biosensia Ltd.
35. BTNX Inc.
36. Boditech Med Inc
37. Xiamen Boson Biotech Co. Ltd
38. Calypte Biomedical Corporation
39. Cepheid, Inc
40. Chembio Diagnostic Systems, Inc
41. Clarity Diagnostics, LLC
42. Confirm Biosciences
43. CTK Biotech, Inc.
44. Daktari Diagnostics
45. Danaher Corporation
46. Dexcom, Inc
47. DIALAB GmbH
48. DiaSys Diagnostic Systems GmbH
49. Diazyme Laboratories, Inc.
50. DNA Electronics Ltd. (DNAe)
51. EKF Diagnostics Holdings plc
52. ELITechGroup, Inc.
53. Eurolyser Diagnostica GmbH
54. Exact Sciences Corporation
55. Exalenz Bioscience Ltd
56. Genedrive plc
57. GeTein BioMedical, Inc.
58. Helena Laboratories
59. Hemosure, Inc.
60. Immunostics, Inc.
61. Instrumentation Laboratory
62. JAL Innovation PTE LTD
63. Jant Pharmacal Corporation
64. LamdaGen Corporation
65. LifeScan, Inc
66. LifeSign, LLC
67. MBio Diagnostics, Inc (Now LightDeck Diagnostics)
68. Medix Biochemica
69. Medtronic, Inc
70. A. Menarini Diagnostics S.R.L.
71. Meridian Bioscience, Inc
72. Nano-Ditech Corporation
73. Noble Medical, Inc
74. Nova Biomedical, Corp.
75. Oasis Diagnostics Corporation
76. OPKO Health, Inc
77. OPTI Medical Systems, Inc
78. OraSure Technologies, Inc
79. Polymed Therapeutics Inc.
80. Preventis GmbH
81. Princeton Biomeditech Corporation
82. QuantuMDx Group Limited
83. Radiometer Medical A/S
84. Response Biomedical Corp
85. Reszon Diagnostics International Sdn. Bhd.
86. Samsung Healthcare
87. Savyon Diagnostics
88. Sekisui Diagnostics LLC
89. Siloam Biosciences, Inc
90. Sysmex Corporation
91. TECHLAB, Inc.
92. Teco Diagnostics
93. Trinity Biotech PLC
94. Trividia Health
95. Tulip Diagnostics Ltd
96. Veredus Laboratories PTE Ltd
97. Vircell 98. WAMA Diagnostica
99. Wave 80 Biosciences
100. Werfen 101. Quidel Corporation
102. Thermo Fisher Scientific
103. Mesa Biotech Inc
104. GeneSTAT Molecular Diagnostics, LLC
105. Biocartis Group NV
106. Johnson and Johnson Service, Inc.
Data Source
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies:
Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies:
Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
The global point of care testing (POCT) market is predicted to reach nearly US$ 65 Billion by 2028. Point-of-care (POC) testing has skyrocketed in the last 20 years as demand for accurate and fast testing has blossomed both inside and outside the hospital setting. POCT or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours.
Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Furthermore, rising incidence of infectious diseases and chronic conditions such as cardiovascular diseases and diabetes in developing countries such as India and China have stimulated demand for point of care testing services. As per statistics of the International Diabetes Federation, in 2021, approximately 537 million adults (20-79 years) are living with diabetes globally, and it is estimated to reach 643 million by 2030 and 783 million by 2045. Hence, growing infectious diseases and chronic conditions will enhance the point of care testing market in the near future.
Impact of COVID-19 on Global Point of Care Testing Market
The COVID–19 outbreak has become a global stress test. The disease has infected around 596.2 million people worldwide. Globally the death toll has reached 6,456,879 according to the latest statistics from the Worldometers (as of August 16, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak stirred an unprecedented public health concern across the globe and has positively impacted the point of care testing market growth.
The need for speedy diagnostic results has made point-of-care testing a vital diagnostic tool. The novel coronavirus has accelerated the research and development activities in the point-of-care diagnostics market. The usage of POC kits in COVID-19 diagnosis has increased at a significant pace owing to multiple advantages such as smaller size, portability, convenience, and precise outcomes, among others. These tests are capable of operating in any low-resource setting including home care settings and are needed to adequately combat the COVID-19 pandemic.
By Diagnostics Segment - Global Point of Care Testing Market & Forecast
Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment. Increasing prevalence of diabetes in developing as well as developed economies and the rising inclination of patients towards home testing is the major driver that will drive segmental growth over the forecast timeframe.
The infectious diseases segment held second largest revenue share in 2021. Infectious diseases are the primary cause of mortality globally, and according to figures from the Clinical Microbiology and Infection journal, they claim over 14 million lives annually, making up around 25% of the 56 million deaths recorded worldwide. Infectious disease testing has shifted from centralized to decentralized POC testing, resulting in better patient care. The market is being driven by increased demand for quick tests, which has prompted industry players to deliver POC solutions to decentralized regions. For instance, Abbott has introduced ID NOW, the world's quickest molecular POC test, which provides COVID-19 findings in 13 minutes and is usable in a variety of decentralized healthcare settings.
Cardiac marker segment is expected to grow at a significant rate during the forecast period. The growing prevalence of cardiovascular ailments, increasing purchasing power, rise in the geriatric population, associated with high susceptibility to chronic diseases related to cardiac disorders, and economical diagnosis of chronic diseases in rural areas is expected to drive the market for cardiac markers.
By Mode - Global Point of Care Testing Market & Forecast
On the basis of mode, the point of care testing market is dominated by OTC-based testing segment. The segment is dominating the overall POCT market in 2021 as these tests are cost-effective as well as easy operative in nature. High segmental growth is attributed to rising number of OTC testing such as blood glucose tests and pregnancy tests that provides result in few seconds. These tests do not require skilled professional to perform and can be self-tested by individuals, thereby boosting the market growth. The Prescription based testing segment is expected to grow at the highest rate during the forecast period.
By Platform - Global Point of Care Testing Market & Forecast
By platform, the Lateral Flow Assays (LFA) segment accounted for largest revenue share in 2021. POC tests based on lateral flow assays are increasingly being employed to replace long, conventional laboratory processes. Lateral flow assays are simple devices used to detect the presence or absence of target analytes in samples. These assays help in detecting and quantifying analytes in complex mixtures and provide results within 30 minutes after the sample is placed on the device. The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe. Rapid immunoassays improve quality of care through its performance at point of care facilities, such as student health clinics, labor and delivery suites and emergency rooms. The cost-effectiveness offered by these immunoassays will influence segment growth during the forecast period.
By End Users - Global Point of Care Testing Market & Forecast
Based on end users, the point of care testing market is segmented into Hospitals, Clinics, Laboratories, Home Care and Assisted Living Healthcare Facilities. Hospitals held majority of the point of care testing market, followed by Clinics. Increase in prevalence of chronic conditions such as cancer and cardiovascular diseases that require proper monitoring and prefer minimally invasive procedures are carried out in hospitals and clinics. The home care segment is expected to grow at the highest rate during the forecast period driven by increasing preference for home and remote monitoring and rising demand for rapid tests among home care users.
By Region - Global Point of Care Testing Market & Forecast
The point of care testing market, by region, is dominated by North America and is expected to maintain its position throughout the forecast period. This can be attributed to rising prevalence of chronic disorders and infectious diseases, which need portable and rapid diagnosis, increasing number of product approvals, and rising government initiatives to support the adoption of POCT in this region. Europe held second highest share of the point of care testing market. Asia-Pacific point of care testing market is expected to grow at the fastest rate during the forecast period driven by growing geriatric population base, rising prevalence of target diseases, increasing demand for home healthcare and the introduction of new products enabled with advanced technologies.
iGATE RESEARCH report titled “Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028” provides a comprehensive analysis of the Global Point of Care Testing Market.
This 270 Page report with 78 Figures and 12 Tables has been analyzed from 11 View Points:
1) Global - Point of Care Testing Market & Forecast (2010 - 2028)
2) Impact of COVID-19 on Global Point of Care Testing Market
3) Global - Point of Care Testing Market Share and Forecast (2010 - 2028)
4) By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)
5) By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)
6) By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)
7) By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)
8) By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)
9) Global Point of Care Testing Market - Recent Developments
10) Global Point of Care Testing Market - 106 Company Profiles
11) Global Point of Care Testing Market - Growth Drivers & Challenges
By Diagnostics Segment - Global Point of Care Testing Market & Forecast
1. Blood Glucose Testing
2. Cardiac Marker Testing
3. Lipid Panel/Cholesterol Testing
4. Coagulation Testing
5. Infectious Disease Testing
6. Urinalysis Testing
7. Drug of Abuse Testing
8. Fecal Occult Blood Testing
9. Pregnancy & Fertility Testing
10. Tumor Marker Testing
11. Critical Care Testing
12. HbA1c Testing
13. Clinical Chemistry Testing
14. Bilirubin Testing
15. Hematology Testing
By Mode - Global Point of Care Testing Market & Forecast
- Prescription-based Testing
- OTC-based Testing
- Lateral Flow Assays
- Immunoassays
- Microfluidics
- Dipsticks
- Molecular Diagnostics
- Others
1. Hospitals
2. Clinics
3. Laboratories
4. Assisted Living Healthcare Facilities
5. Home Care
By Region - Global Point of Care Testing Market & Forecast
1. North America
2. Europe
3. Asia Pacific
4. Latin America
5. Middle East & Africa
Global Point of Care Testing Market - 106 Company Profiles
1. Abbott Laboratories
2. Siemens Healthineers
3. Roche Diagnostics
4. Quest Diagnostics
5. Becton, Dickinson and Company
6. ACON Laboratories
7. Abaxis, Inc
8. Abingdon Health, Ltd
9. Access Bio, Inc.
10. AccuBioTech Co, Ltd.
11. Akers Biosciences, Inc.
12. Alfa Scientific Designs, Inc
13. American Bio Medica Corporation
14. AmniSure International
15. Aquila Diagnostic Systems, Inc
16. ARKRAY Inc
17. Artron Laboratories Inc.
18. Ascensia Diabetes Care Holdings AG
19. Immune IQ (Formerly Ativa)
20. Atlas Link Biotech Co., Ltd
21. Audit Diagnostics
22. Augurix Diagnostics
23. Autobio Diagnostics Co., Ltd
24. Axxin
25. Beckman Coulter, Inc
26. Bhat Bio-Tech India Private Ltd.
27. bioLytical Laboratories
28. BioMedomics, Inc
29. Biomerica, Inc.
30. bioMerieux SA
31. Biophor Diagnostics, Inc
32. Bio-Rad Laboratories Inc.
33. Bioscan Screening Systems, Inc.
34. Biosensia Ltd.
35. BTNX Inc.
36. Boditech Med Inc
37. Xiamen Boson Biotech Co. Ltd
38. Calypte Biomedical Corporation
39. Cepheid, Inc
40. Chembio Diagnostic Systems, Inc
41. Clarity Diagnostics, LLC
42. Confirm Biosciences
43. CTK Biotech, Inc.
44. Daktari Diagnostics
45. Danaher Corporation
46. Dexcom, Inc
47. DIALAB GmbH
48. DiaSys Diagnostic Systems GmbH
49. Diazyme Laboratories, Inc.
50. DNA Electronics Ltd. (DNAe)
51. EKF Diagnostics Holdings plc
52. ELITechGroup, Inc.
53. Eurolyser Diagnostica GmbH
54. Exact Sciences Corporation
55. Exalenz Bioscience Ltd
56. Genedrive plc
57. GeTein BioMedical, Inc.
58. Helena Laboratories
59. Hemosure, Inc.
60. Immunostics, Inc.
61. Instrumentation Laboratory
62. JAL Innovation PTE LTD
63. Jant Pharmacal Corporation
64. LamdaGen Corporation
65. LifeScan, Inc
66. LifeSign, LLC
67. MBio Diagnostics, Inc (Now LightDeck Diagnostics)
68. Medix Biochemica
69. Medtronic, Inc
70. A. Menarini Diagnostics S.R.L.
71. Meridian Bioscience, Inc
72. Nano-Ditech Corporation
73. Noble Medical, Inc
74. Nova Biomedical, Corp.
75. Oasis Diagnostics Corporation
76. OPKO Health, Inc
77. OPTI Medical Systems, Inc
78. OraSure Technologies, Inc
79. Polymed Therapeutics Inc.
80. Preventis GmbH
81. Princeton Biomeditech Corporation
82. QuantuMDx Group Limited
83. Radiometer Medical A/S
84. Response Biomedical Corp
85. Reszon Diagnostics International Sdn. Bhd.
86. Samsung Healthcare
87. Savyon Diagnostics
88. Sekisui Diagnostics LLC
89. Siloam Biosciences, Inc
90. Sysmex Corporation
91. TECHLAB, Inc.
92. Teco Diagnostics
93. Trinity Biotech PLC
94. Trividia Health
95. Tulip Diagnostics Ltd
96. Veredus Laboratories PTE Ltd
97. Vircell 98. WAMA Diagnostica
99. Wave 80 Biosciences
100. Werfen 101. Quidel Corporation
102. Thermo Fisher Scientific
103. Mesa Biotech Inc
104. GeneSTAT Molecular Diagnostics, LLC
105. Biocartis Group NV
106. Johnson and Johnson Service, Inc.
Data Source
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies:
Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies:
Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.
Table of Contents
270 Pages
- 1. Executive Summary
- 2. Impact of COVID-19 on Global Point of Care Testing Market
- 3. Global - Point of Care Testing Market & Forecast (2010 - 2028)
- 4. Global - Point of Care Testing Market Share & Forecast (2010 - 2028)
- 4.1 By Diagnostics Segment - Global Point of Care Testing Market Share & Forecast
- 4.2 By Mode - Global Point of Care Testing Market Share & Forecast
- 4.3 By Platform - Global Point of Care Testing Market Share & Forecast (2015 - 2028)
- 4.4 By End Users - Global Point of Care Testing Market Share & Forecast
- 4.5 By Region - Point of Care Testing Market Share & Forecast
- 5. By Diagnostics Segment - Global Point of Care Testing Market & Forecast (2010 - 2028)
- 5.1 Blood Glucose Testing Market & Forecast
- 5.2 Cardiac Marker Testing Market & Forecast
- 5.3 Lipid Panel/Cholesterol Testing Market & Forecast
- 5.4 Coagulation Testing Market & Forecast
- 5.5 Infectious Disease Testing Market & Forecast
- 5.6 Urinalysis Testing Market & Forecast
- 5.7 Drug of Abuse Testing Market & Forecast
- 5.8 Fecal Occult Blood Testing Market & Forecast
- 5.9 Pregnancy & Fertility Testing Market & Forecast
- 5.10 Tumor Marker Testing Market & Forecast
- 5.11 Critical Care Testing Market & Forecast
- 5.12 HbA1c Testing Market & Forecast
- 5.13 Clinical Chemistry Testing Market & Forecast
- 5.14 Bilirubin Testing Market & Forecast
- 5.15 Hematology Testing Market & Forecast
- 6. By Mode - Global Point of Care Testing Market & Forecast (2010 - 2028)
- 6.1 Prescription-based Testing Market & Forecast
- 6.2 OTC-based Testing Market & Forecast
- 7. By Platform - Global Point of Care Testing Market & Forecast (2015 - 2028)
- 7.1 Global - Point of Care Diagnostics Market for Lateral Flow Assays
- 7.2 Global - Point of Care Diagnostics Market for Immunoassays
- 7.3 Global - Point of Care Diagnostics Market for Microfluidics
- 7.4 Global - Point of Care Diagnostics Market for Dipsticks
- 7.5 Global - Point of Care Diagnostics Market for Molecular Diagnostics
- 7.6 Global - Point of Care Diagnostics Market for Other Platforms
- 8. By End Users - Global Point of Care Testing Market & Forecast (2010 - 2028)
- 8.1 Hospitals - Point of Care Testing Market & Forecast
- 8.2 Clinics - Point of Care Testing Market & Forecast
- 8.3 Laboratories - Point of Care Testing Market & Forecast
- 8.4 Assisted Living Healthcare Facilities - Point of Care Testing Market & Forecast
- 8.5 Home Care - Point of Care Testing Market & Forecast
- 9. By Region - Global Point of Care Testing Market & Forecast (2010 - 2028)
- 9.1 North America - Point of Care Testing Market & Forecast
- 9.2 Europe - Point of Care Testing Market & Forecast
- 9.3 Asia Pacific - Point of Care Testing Market & Forecast
- 9.4 Latin America - Point of Care Testing Market & Forecast
- 9.5 Middle East and Africa - Point of Care Testing Market & Forecast
- 10. Global Point of Care Testing Market - Recent Developments
- 11. Point of Care Testing Market - Company Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Company Overview
- 11.1.2 Product Portfolio
- 11.1.3 Financial Insight
- 11.1.4 Business Strategy
- 11.2 Siemens Healthineers
- 11.2.1 Company Overview
- 11.2.2 Product Portfolio
- 11.2.3 Financial Insight
- 11.2.4 Business Strategy
- 11.3 Roche Diagnostics
- 11.3.1 Company Overview
- 11.3.2 Product Portfolio
- 11.3.3 Financial Insight
- 11.3.4 Business Strategy
- 11.4 Quest Diagnostics
- 11.4.1 Company Overview
- 11.4.2 Product Portfolio
- 11.4.3 Financial Insight
- 11.4.4 Business Strategy
- 11.5 Becton, Dickinson and Company
- 11.5.1 Company Overview
- 11.5.2 Product Portfolio
- 11.5.3 Financial Insight
- 11.5.4 Business Strategy
- 11.6 ACON Laboratories
- 11.6.1 Company Overview
- 11.6.2 Product Portfolio
- 11.7 Abaxis, Inc.
- 11.7.1 Company Overview
- 11.7.2 Product Portfolio
- 11.8 Abingdon Health, Ltd.
- 11.8.1 Company Overview
- 11.8.2 Product Portfolio
- 11.9 Access Bio, Inc.
- 11.9.1 Company Overview
- 11.9.2 Product Portfolio
- 11.10 AccuBioTech Co, Ltd.
- 11.11 Akers Biosciences, Inc.
- 11.12 Alfa Scientific Designs, Inc
- 11.13 American Bio Medica Corporation
- 11.14 AmniSure International
- 11.15 Aquila Diagnostic Systems, Inc
- 11.16 ARKRAY Inc
- 11.17 Artron Laboratories Inc.
- 11.18 Ascensia Diabetes Care Holdings AG
- 11.19 Immune IQ (Formerly Ativa)
- 11.20 Atlas Link Biotech Co., Ltd
- 11.21 Audit Diagnostics
- 11.22 Augurix Diagnostics
- 11.23 Autobio Diagnostics Co., Ltd
- 11.24 Axxin
- 11.25 Beckman Coulter, Inc
- 11.26 Bhat Bio-Tech India Private Ltd. (BBI)
- 11.27 bioLytical Laboratories
- 11.28 BioMedomics, Inc
- 11.29 Biomerica, Inc.
- 11.30 bioMerieux SA
- 11.31 Biophor Diagnostics, Inc
- 11.32 Biosensia Ltd.
- 11.33 Bio-Rad Laboratories Inc.
- 11.34 Bioscan Screening Systems, Inc.
- 11.35 BTNX Inc.
- 11.36 Boditech Med Inc
- 11.37 Xiamen Boson Biotech Co. Ltd
- 11.38 Calypte Biomedical Corporation
- 11.39 Cepheid, Inc
- 11.40 Chembio Diagnostic Systems, Inc.
- 11.41 Clarity Diagnostics, LLC
- 11.42 Confirm Biosciences
- 11.43 CTK Biotech, Inc.
- 11.44 Daktari Diagnostics
- 11.45 Danaher Corporation
- 11.46 Dexcom, Inc
- 11.47 DIALAB GmbH
- 11.48 DiaSys Diagnostic Systems GmbH
- 11.49 Diazyme Laboratories, Inc.
- 11.50 DNA Electronics Ltd. (DNAe)
- 11.51 EKF Diagnostics Holdings plc
- 11.52 ELITechGroup, Inc.
- 11.53 Eurolyser Diagnostica GmbH
- 11.54 Exact Sciences Corporation
- 11.55 Exalenz Bioscience Ltd.
- 11.56 Genedrive plc
- 11.57 GeTein BioMedical, Inc.
- 11.58 Helena Laboratories
- 11.59 Hemosure, Inc.
- 11.60 Immunostics, Inc.
- 11.61 Instrumentation Laboratory
- 11.62 JAL Innovation PTE LTD
- 11.63 Jant Pharmacal Corporation
- 11.64 LamdaGen Corporation
- 11.65 LifeScan, Inc
- 11.66 LifeSign, LLC
- 11.67 MBio Diagnostics, Inc (Now LightDeck Diagnostics)
- 11.68 Medix Biochemica
- 11.69 Medtronic, Inc.
- 11.70 A. Menarini Diagnostics S.R.L.
- 11.71 Meridian Bioscience, Inc
- 11.72 Nano-Ditech Corporation
- 11.73 Noble Medical, Inc
- 11.74 Nova Biomedical, Corp.
- 11.75 Oasis Diagnostics Corporation
- 11.76 OPKO Health, Inc
- 11.77 OPTI Medical Systems, Inc
- 11.78 OraSure Technologies, Inc
- 11.79 Polymed Therapeutics Inc.
- 11.80 Preventis GmbH
- 11.81 Princeton Biomeditech Corporation
- 11.82 QuantuMDx Group Limited
- 11.83 Radiometer Medical A/S
- 11.84 Response Biomedical Corp
- 11.85 Reszon Diagnostics International Sdn. Bhd.
- 11.86 Samsung Healthcare
- 11.87 Savyon Diagnostics
- 11.88 Sekisui Diagnostics LLC
- 11.89 Siloam Biosciences, Inc
- 11.90 Sysmex Corporation
- 11.91 TECHLAB, Inc.
- 11.92 Teco Diagnostics
- 11.93 Trinity Biotech PLC
- 11.94 Trividia Health
- 11.95 Tulip Diagnostics Ltd
- 11.96 Veredus Laboratories PTE Ltd
- 11.97 Vircell
- 11.98 WAMA Diagnostica
- 11.99 Wave 80 Biosciences
- 11.100 Werfen
- 11.101 Quidel Corporation
- 11.102 Thermo Fisher Scientific
- 11.103 Mesa Biotech Inc.
- 11.104 GeneSTAT Molecular Diagnostics, LLC
- 11.105 Biocartis Group NV
- 11.106 Johnson and Johnson Service, Inc.
- 12. Global Point of Care Testing Market - Growth Drivers
- 12.1 Point-of-care Testing: A Step to the Future
- 12.2 High Prevalence of Chronic and Infectious Diseases
- 12.3 Continued Expansion of Point of Care Including Self Testing
- 12.3.1 The Promise of Point-of-Care Testing
- 12.3.2 Future of Point of Care Testing - The ‘Worried Well’
- 12.3.3 Hub and Spoke
- 12.3.4 Education
- 12.4 Technological Advancement in POCT to Spur Market Demand
- 13. Global Point of Care Testing Market - Challenges
- 13.1 Point of Care (POC) Testing Barriers in Low & Middle-Income Countries
- 13.1.1 Barriers to Adoption & Scale-up of POC Technologies
- 13.1.2 Technical, Administrative & Operational Barriers of Point of Care Tests
- 13.1.3 Health System Related Barriers of Point of Care Tests
- 13.1.4 Economic Barriers of Point of Care Tests
- 13.2 Policy/Regulatory Guidelines and Funding Challenges
- 13.3 Infrastructure Barriers and Challenges with POC Diagnostics Development
- List of Figures:
- Figure 3-1: Global - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 3-2: Global - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 5-1: Global - Blood Glucose Testing Market (Million US$), 2010 - 2021
- Figure 5-2: Global - Forecast for Blood Glucose Testing Market (Million US$), 2022 - 2028
- Figure 5-3: Global - Cardiac Marker Testing Market (Million US$), 2010 - 2021
- Figure 5-4: Global - Forecast for Cardiac Marker Testing Market (Million US$), 2022 - 2028
- Figure 5-5: Global - Lipid Panel/Cholesterol Testing Market (Million US$), 2010 - 2021
- Figure 5-6: Global - Forecast for Lipid Panel/Cholesterol Testing Market (Million US$), 2022 - 2028
- Figure 5-7: Global - Coagulation Testing Market (Million US$), 2010 - 2021
- Figure 5-8: Global - Forecast for Coagulation Testing Market (Million US$), 2022 - 2028
- Figure 5-9: Global - Infectious Disease Testing Market (Million US$), 2010 - 2021
- Figure 5-10: Global - Forecast for Infectious Disease Testing Market (Million US$), 2022 - 2028
- Figure 5-11: Global - Urinalysis Testing Market (Million US$), 2010 - 2021
- Figure 5-12: Global - Forecast for Urinalysis Testing Market (Million US$), 2022 - 2028
- Figure 5-13: Global - Drug of Abuse Testing Market (Million US$), 2010 - 2021
- Figure 5-14: Global - Forecast for Drug of Abuse Testing Market (Million US$), 2022 - 2028
- Figure 5-15: Global - Fecal Occult Blood Testing Market (Million US$), 2010 - 2021
- Figure 5-16: Global - Forecast for Fecal Occult Blood Testing Market (Million US$), 2022 - 2028
- Figure 5-17: Global - Pregnancy & Fertility Testing Market (Million US$), 2010 - 2021
- Figure 5-18: Global - Forecast for Pregnancy & Fertility Testing Market (Million US$), 2022 - 2028
- Figure 5-19: Global - Tumor Marker Testing Market (Million US$), 2010 - 2021
- Figure 5-20: Global - Forecast for Tumor Marker Testing Market (Million US$), 2022 - 2028
- Figure 5-21: Global - Critical Care Testing Market (Million US$), 2010 - 2021
- Figure 5-22: Global - Forecast for Critical Care Testing Market (Million US$), 2022 - 2028
- Figure 5-23: Global - HbA1c Testing Market (Million US$), 2010 - 2021
- Figure 5-24: Global - Forecast for HbA1c Testing Market (Million US$), 2022 - 2028
- Figure 5-25: Global - Clinical Chemistry Testing Market (Million US$), 2010 - 2021
- Figure 5-26: Global - Forecast for Clinical Chemistry Testing Market (Million US$), 2022 - 2028
- Figure 5-27: Global - Bilirubin Testing Market (Million US$), 2010 - 2021
- Figure 5-28: Global - Forecast for Bilirubin Testing Market (Million US$), 2022 - 2028
- Figure 5-29: Global - Hematology Testing Market (Million US$), 2010 - 2021
- Figure 5-30: Global - Forecast for Hematology Testing Market (Million US$), 2022 - 2028
- Figure 6-1: Global - Prescription-based Testing Market (Million US$), 2010 - 2021
- Figure 6-2: Global - Forecast for Prescription-based Testing Market (Million US$), 2022 - 2028
- Figure 6-3: Global - OTC-based Testing Market (Million US$), 2010 - 2021
- Figure 6-4: Global - Forecast for OTC-based Testing Market (Million US$), 2022 - 2028
- Figure 7-1: Global POCT - Lateral Flow Assays Market (Million US$), 2015 - 2021
- Figure 7-2: Global POCT - Forecast for Lateral Flow Assays Market (Million US$), 2022 - 2028
- Figure 7-3: Global POCT - Immunoassays Market (Million US$), 2015 - 2021
- Figure 7-4: Global POCT - Forecast for Immunoassays Market (Million US$), 2022 - 2028
- Figure 7-5: Global POCT - Microfluidics Market (Million US$), 2015 - 2021
- Figure 7-6: Global POCT - Forecast for Microfluidics Market (Million US$), 2022 - 2028
- Figure 7-7: Global POCT - Dipsticks Market (Million US$), 2015 - 2021
- Figure 7-8: Global POCT - Forecast for Dipsticks Market (Million US$), 2022 - 2028
- Figure 7-9: Global POCT - Molecular Diagnostics Market (Million US$), 2015 - 2021
- Figure 7-10: Global POCT - Forecast for Molecular Diagnostics Market (Million US$), 2022 - 2028
- Figure 7-11: Global POCT - Other Platforms Market (Million US$), 2015 - 2021
- Figure 7-12: Global POCT - Forecast for Other Platforms Market (Million US$), 2022 - 2028
- Figure 8-1: Hospitals - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 8-2: Hospitals - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 8-3: Clinics - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 8-4: Clinics - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 8-5: Laboratories - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 8-6: Laboratories - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 8-7: Assisted Living Healthcare Facilities - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 8-8: Assisted Living Healthcare Facilities - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 8-9: Home Care - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 8-10: Home Care - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 9-1: North America - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 9-2: North America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 9-3: Europe - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 9-4: Europe - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 9-5: Asia Pacific - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 9-6: Asia Pacific - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 9-7: Latin America - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 9-8: Latin America - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 9-9: Middle East and Africa - Point of Care Testing Market (Million US$), 2010 - 2021
- Figure 9-10: Middle East and Africa - Forecast for Point of Care Testing Market (Million US$), 2022 - 2028
- Figure 11-1: Abbott Laboratories - Global Diagnostics Sales (Million US$), 2013 - 2021
- Figure 11-2: Abbott Laboratories - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
- Figure 11-3: Siemens Healthineers - Global Diagnostics Sales (Million US$), 2013 - 2021
- Figure 11-4: Siemens Healthineers - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
- Figure 11-5: Roche Diagnostics - Global Sales (Million US$), 2013 - 2021
- Figure 11-6: Roche Diagnostics - Forecast for Global Sales (Million US$), 2022 - 2028
- Figure 11-7: Quest Diagnostics - Net Sales (Million US$), 2014 - 2021
- Figure 11-8: Quest Diagnostics - Forecast for Net Sales (Million US$), 2022 - 2028
- Figure 11-9: Becton, Dickinson and Company - Global Diagnostics Sales (Million US$), 2014 - 2021
- Figure 11-10: Becton, Dickinson and Company - Forecast for Global Diagnostics Sales (Million US$), 2022 - 2028
- List of Tables:
- Table 4-1: By Diagnostics Segment - Global Point of Care Testing Market Share (Percent), 2010 - 2021
- Table 4-2: By Diagnostics Segment - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
- Table 4-3: By Mode - Global Point of Care Testing Market Share (Percent), 2010 - 2021
- Table 4-4: By Mode - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
- Table 4-5: By Platform - Global Point of Care Testing Market Share (Percent), 2015 - 2021
- Table 4-6: By Platform - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
- Table 4-7: By End Users - Global Point of Care Testing Market Share (Percent), 2010 - 2021
- Table 4-8: By End Users - Forecast for Global Point of Care Testing Market Share (Percent), 2022 - 2028
- Table 4-9: By Region - Point of Care Testing Market Share (Percent), 2010 - 2021
- Table 4-10: By Region - Forecast for Point of Care Testing Market Share (Percent), 2022 - 2028
- Table 11-1: Eurolyser Diagnostica GmbH - Point-of-Care Test Portfolio
- Table 13-1: POCT - Barriers to Adoption and Scale-up of POC Technologies
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
